South Glastonbury, CT, United States of America

Chakrapani Subramanyam

This inventor holds 37 USPTO granted patents and 11 published patent applications, plus 12 CIPO patents and 18 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Pfizer Corporation, Pfizer Products Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chakrapani Subramanyam. Retrieved from https://idiyas.com/inventor/chakrapani-subramanyam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 11)

% Patents Active = 81.1

CIPO Patents = 12 (Patent Applications = 5)

EPO Patents = 18 (Patent Applications = 25)

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 79(Granted Patents)

Location History:

South Glastonburty, CT (US) (2014 - 2015)
South Glastonbury, CT (US) (2006 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Cytotoxic Agents

Heteroaromatic Compounds

Dopamine D1 Ligands

Neurodegenerative Disorders

Spliceostatin Analogs

Bifunctional Agents

Pyrido[1,2-a]Pyrazines

Casein Kinase Inhibitors

Bicyclic Pyridinones

Calicheamicin Derivatives

Tubulysin Analogs

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653901 - ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (2026-06-16),

2. 12636377 - ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (2026-05-26),

3. 11993625 - Calicheamicin derivatives and antibody drug conjugates thereof (2024-05-28),

4. 11833216 - Anti-EDB antibodies and antibody-drug conjugates (2023-12-05),

5. 11365263 - Bifunctional cytotoxic agents containing the CTI pharmacophore (2022-06-21),

6. 10870706 - Bifunctional cytotoxic agents containing the CTI pharmacophore (2020-12-22),

7. 10723727 - Tubulysin analogs and methods for their preparation (2020-07-28),

8. 10391182 - Bifunctional cytotoxic agents (2019-08-27),

9. 10086085 - Bifunctional cytotoxic agents (2018-10-02),

10. 10077272 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-09-18),

11. 9868744 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-01-16),

12. 9856263 - Heteroaromatic compounds and their use as dopamine D1 ligands (2018-01-02),

13. 9850232 - Heteroaromatic compounds and their use as dopamine D1 ligands (2017-12-26),

14. 9764040 - Spliceostatin analogs and methods for their preparation (2017-09-19),

15. 9751877 - Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders (2017-09-05),

Title: The Innovative Journey of Chakrapani Subramanyam

Introduction: Chakrapani Subramanyam, a talented inventor hailing from South Glastonbury, CT (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: Chakrapani Subramanyam holds several patents in various technological areas, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his illustrious career, Chakrapani Subramanyam has been recognized for his groundbreaking inventions that have revolutionized industries. His commitment to pushing the boundaries of what is possible has led to numerous successful projects.

Collaborations: Chakrapani Subramanyam has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Chakrapani Subramanyam's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventions. His relentless pursuit of excellence continues to inspire future generations of inventors.

Profile summary based on public USPTO records.